![Pierre Kyme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Kyme
Public Communications Contact bei
ARMATA PHARMACEUTICALS, INC.
Vermögen: 36 446 $ am 31.05.2026
Profil
Pierre Kyme currently works at Special Phage Services Pty Ltd., as Director, Special Phage Holdings Pty Ltd., as Director, AmpliPhi Australia Pty Ltd., as Director, C3J Therapeutics, Inc., as Director-Product Development from 2012, and Armata Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Dr. Kyme received his doctorate degree from The University of Sydney.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2026 | 4 461 ( 0,01 % ) | 36 446 $ | 31.05.2026 |
Aktive Positionen von Pierre Kyme
| Unternehmen | Position | Beginn |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Public Communications Contact | - |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Corporate Officer/Principal | 01.01.2012 |
AmpliPhi Australia Pty Ltd.
 AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Direktor/Vorstandsmitglied | - |
Special Phage Holdings Pty Ltd.
 Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Direktor/Vorstandsmitglied | - |
Special Phage Services Pty Ltd.
 Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Direktor/Vorstandsmitglied | - |
Ausbildung von Pierre Kyme
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Special Phage Services Pty Ltd.
Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Health Technology |
Special Phage Holdings Pty Ltd.
Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Health Technology |
AmpliPhi Australia Pty Ltd.
AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
